Corresponding studies have revealed that even when a BLA was clearly indicated and the reported alleged allergic reaction was weak, with a low probability for an IgE-mediated type I reaction, and where an alternative BLA would have been possible, alternative antibiotics were still given, with all the aforementioned disadvantages for the affected patients [3, 10]. This evidence concerns the gene IGHE and allergic disease.